ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Kidney Cancer or Renal Cancer Market Research Report 2024
Published Date: July 2024
|
Report Code: QYRE-Auto-5T17616
Home | Market Reports | Health| Health Conditions| Cancer
Global Kidney Cancer or Renal Cancer Market Research Report 2024
BUY CHAPTERS

Global Kidney Cancer or Renal Cancer Market Research Report 2024

Code: QYRE-Auto-5T17616
Report
July 2024
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
Gilead Sciences
Roche
Bristol–Myers Squibb
Amgen Inc
Astrazeneca plc
Merck
Takeda
Merck KGaA
Seagen
Eli Lilly
Pfizer Inc
GSK

Kidney Cancer or Renal Cancer Market

Kidney cancer, also known as renal cancer, refers to cancer that originates in the kidneys. The kidneys are two bean-shaped organs located on either side of the spine, responsible for filtering blood, removing waste, and producing urine. Kidney cancer can take several forms, but the most common type is renal cell carcinoma (RCC).
The global Kidney Cancer or Renal Cancer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Kidney Cancer or Renal Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Kidney Cancer or Renal Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Kidney Cancer or Renal Cancer in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Kidney Cancer or Renal Cancer include Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, Merck KGaA, Seagen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Kidney Cancer or Renal Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney Cancer or Renal Cancer.
The Kidney Cancer or Renal Cancer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Kidney Cancer or Renal Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Kidney Cancer or Renal Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Kidney Cancer or Renal Cancer Market Report

Report Metric Details
Report Name Kidney Cancer or Renal Cancer Market
Segment by Type
  • Targeted Therapy
  • Chemotherapy
  • Immunotherapy
Segment by Application
  • Hospital
  • Pharmacy
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, Merck KGaA, Seagen, Eli Lilly, Pfizer, GSK
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Kidney Cancer or Renal Cancer company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Kidney Cancer or Renal Cancer Market report?

Ans: The main players in the Kidney Cancer or Renal Cancer Market are Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, Merck KGaA, Seagen, Eli Lilly, Pfizer, GSK

What are the Application segmentation covered in the Kidney Cancer or Renal Cancer Market report?

Ans: The Applications covered in the Kidney Cancer or Renal Cancer Market report are Hospital, Pharmacy, Other

What are the Type segmentation covered in the Kidney Cancer or Renal Cancer Market report?

Ans: The Types covered in the Kidney Cancer or Renal Cancer Market report are Targeted Therapy, Chemotherapy, Immunotherapy

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Kidney Cancer or Renal Cancer Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Targeted Therapy
1.2.3 Chemotherapy
1.2.4 Immunotherapy
1.3 Market by Application
1.3.1 Global Kidney Cancer or Renal Cancer Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Kidney Cancer or Renal Cancer Market Perspective (2019-2030)
2.2 Global Kidney Cancer or Renal Cancer Growth Trends by Region
2.2.1 Global Kidney Cancer or Renal Cancer Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Kidney Cancer or Renal Cancer Historic Market Size by Region (2019-2024)
2.2.3 Kidney Cancer or Renal Cancer Forecasted Market Size by Region (2025-2030)
2.3 Kidney Cancer or Renal Cancer Market Dynamics
2.3.1 Kidney Cancer or Renal Cancer Industry Trends
2.3.2 Kidney Cancer or Renal Cancer Market Drivers
2.3.3 Kidney Cancer or Renal Cancer Market Challenges
2.3.4 Kidney Cancer or Renal Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Kidney Cancer or Renal Cancer Players by Revenue
3.1.1 Global Top Kidney Cancer or Renal Cancer Players by Revenue (2019-2024)
3.1.2 Global Kidney Cancer or Renal Cancer Revenue Market Share by Players (2019-2024)
3.2 Global Kidney Cancer or Renal Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Kidney Cancer or Renal Cancer Revenue
3.4 Global Kidney Cancer or Renal Cancer Market Concentration Ratio
3.4.1 Global Kidney Cancer or Renal Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Kidney Cancer or Renal Cancer Revenue in 2023
3.5 Global Key Players of Kidney Cancer or Renal Cancer Head office and Area Served
3.6 Global Key Players of Kidney Cancer or Renal Cancer, Product and Application
3.7 Global Key Players of Kidney Cancer or Renal Cancer, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Kidney Cancer or Renal Cancer Breakdown Data by Type
4.1 Global Kidney Cancer or Renal Cancer Historic Market Size by Type (2019-2024)
4.2 Global Kidney Cancer or Renal Cancer Forecasted Market Size by Type (2025-2030)
5 Kidney Cancer or Renal Cancer Breakdown Data by Application
5.1 Global Kidney Cancer or Renal Cancer Historic Market Size by Application (2019-2024)
5.2 Global Kidney Cancer or Renal Cancer Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Kidney Cancer or Renal Cancer Market Size (2019-2030)
6.2 North America Kidney Cancer or Renal Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Kidney Cancer or Renal Cancer Market Size by Country (2019-2024)
6.4 North America Kidney Cancer or Renal Cancer Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Kidney Cancer or Renal Cancer Market Size (2019-2030)
7.2 Europe Kidney Cancer or Renal Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Kidney Cancer or Renal Cancer Market Size by Country (2019-2024)
7.4 Europe Kidney Cancer or Renal Cancer Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Kidney Cancer or Renal Cancer Market Size (2019-2030)
8.2 Asia-Pacific Kidney Cancer or Renal Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Kidney Cancer or Renal Cancer Market Size by Region (2019-2024)
8.4 Asia-Pacific Kidney Cancer or Renal Cancer Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Kidney Cancer or Renal Cancer Market Size (2019-2030)
9.2 Latin America Kidney Cancer or Renal Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Kidney Cancer or Renal Cancer Market Size by Country (2019-2024)
9.4 Latin America Kidney Cancer or Renal Cancer Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Kidney Cancer or Renal Cancer Market Size (2019-2030)
10.2 Middle East & Africa Kidney Cancer or Renal Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Kidney Cancer or Renal Cancer Market Size by Country (2019-2024)
10.4 Middle East & Africa Kidney Cancer or Renal Cancer Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Kidney Cancer or Renal Cancer Introduction
11.1.4 Novartis Revenue in Kidney Cancer or Renal Cancer Business (2019-2024)
11.1.5 Novartis Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Kidney Cancer or Renal Cancer Introduction
11.2.4 Gilead Sciences Revenue in Kidney Cancer or Renal Cancer Business (2019-2024)
11.2.5 Gilead Sciences Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Kidney Cancer or Renal Cancer Introduction
11.3.4 Roche Revenue in Kidney Cancer or Renal Cancer Business (2019-2024)
11.3.5 Roche Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Kidney Cancer or Renal Cancer Introduction
11.4.4 Bristol-Myers Squibb Revenue in Kidney Cancer or Renal Cancer Business (2019-2024)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Amgen Business Overview
11.5.3 Amgen Kidney Cancer or Renal Cancer Introduction
11.5.4 Amgen Revenue in Kidney Cancer or Renal Cancer Business (2019-2024)
11.5.5 Amgen Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Kidney Cancer or Renal Cancer Introduction
11.6.4 AstraZeneca Revenue in Kidney Cancer or Renal Cancer Business (2019-2024)
11.6.5 AstraZeneca Recent Development
11.7 Merck & Co
11.7.1 Merck & Co Company Details
11.7.2 Merck & Co Business Overview
11.7.3 Merck & Co Kidney Cancer or Renal Cancer Introduction
11.7.4 Merck & Co Revenue in Kidney Cancer or Renal Cancer Business (2019-2024)
11.7.5 Merck & Co Recent Development
11.8 Takeda
11.8.1 Takeda Company Details
11.8.2 Takeda Business Overview
11.8.3 Takeda Kidney Cancer or Renal Cancer Introduction
11.8.4 Takeda Revenue in Kidney Cancer or Renal Cancer Business (2019-2024)
11.8.5 Takeda Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Details
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Kidney Cancer or Renal Cancer Introduction
11.9.4 Merck KGaA Revenue in Kidney Cancer or Renal Cancer Business (2019-2024)
11.9.5 Merck KGaA Recent Development
11.10 Seagen
11.10.1 Seagen Company Details
11.10.2 Seagen Business Overview
11.10.3 Seagen Kidney Cancer or Renal Cancer Introduction
11.10.4 Seagen Revenue in Kidney Cancer or Renal Cancer Business (2019-2024)
11.10.5 Seagen Recent Development
11.11 Eli Lilly
11.11.1 Eli Lilly Company Details
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Kidney Cancer or Renal Cancer Introduction
11.11.4 Eli Lilly Revenue in Kidney Cancer or Renal Cancer Business (2019-2024)
11.11.5 Eli Lilly Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Kidney Cancer or Renal Cancer Introduction
11.12.4 Pfizer Revenue in Kidney Cancer or Renal Cancer Business (2019-2024)
11.12.5 Pfizer Recent Development
11.13 GSK
11.13.1 GSK Company Details
11.13.2 GSK Business Overview
11.13.3 GSK Kidney Cancer or Renal Cancer Introduction
11.13.4 GSK Revenue in Kidney Cancer or Renal Cancer Business (2019-2024)
11.13.5 GSK Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Novartis
Gilead Sciences
Roche
Bristol–Myers Squibb
Amgen Inc
Astrazeneca plc
Merck
Takeda
Merck KGaA
Seagen
Eli Lilly
Pfizer Inc
GSK
List of Tables
 Table 1. Global Kidney Cancer or Renal Cancer Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Targeted Therapy
 Table 3. Key Players of Chemotherapy
 Table 4. Key Players of Immunotherapy
 Table 5. Global Kidney Cancer or Renal Cancer Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Kidney Cancer or Renal Cancer Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global Kidney Cancer or Renal Cancer Market Size by Region (2019-2024) & (US$ Million)
 Table 8. Global Kidney Cancer or Renal Cancer Market Share by Region (2019-2024)
 Table 9. Global Kidney Cancer or Renal Cancer Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 10. Global Kidney Cancer or Renal Cancer Market Share by Region (2025-2030)
 Table 11. Kidney Cancer or Renal Cancer Market Trends
 Table 12. Kidney Cancer or Renal Cancer Market Drivers
 Table 13. Kidney Cancer or Renal Cancer Market Challenges
 Table 14. Kidney Cancer or Renal Cancer Market Restraints
 Table 15. Global Kidney Cancer or Renal Cancer Revenue by Players (2019-2024) & (US$ Million)
 Table 16. Global Kidney Cancer or Renal Cancer Market Share by Players (2019-2024)
 Table 17. Global Top Kidney Cancer or Renal Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer or Renal Cancer as of 2023)
 Table 18. Ranking of Global Top Kidney Cancer or Renal Cancer Companies by Revenue (US$ Million) in 2023
 Table 19. Global 5 Largest Players Market Share by Kidney Cancer or Renal Cancer Revenue (CR5 and HHI) & (2019-2024)
 Table 20. Global Key Players of Kidney Cancer or Renal Cancer, Headquarters and Area Served
 Table 21. Global Key Players of Kidney Cancer or Renal Cancer, Product and Application
 Table 22. Global Key Players of Kidney Cancer or Renal Cancer, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Kidney Cancer or Renal Cancer Market Size by Type (2019-2024) & (US$ Million)
 Table 25. Global Kidney Cancer or Renal Cancer Revenue Market Share by Type (2019-2024)
 Table 26. Global Kidney Cancer or Renal Cancer Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 27. Global Kidney Cancer or Renal Cancer Revenue Market Share by Type (2025-2030)
 Table 28. Global Kidney Cancer or Renal Cancer Market Size by Application (2019-2024) & (US$ Million)
 Table 29. Global Kidney Cancer or Renal Cancer Revenue Market Share by Application (2019-2024)
 Table 30. Global Kidney Cancer or Renal Cancer Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 31. Global Kidney Cancer or Renal Cancer Revenue Market Share by Application (2025-2030)
 Table 32. North America Kidney Cancer or Renal Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 33. North America Kidney Cancer or Renal Cancer Market Size by Country (2019-2024) & (US$ Million)
 Table 34. North America Kidney Cancer or Renal Cancer Market Size by Country (2025-2030) & (US$ Million)
 Table 35. Europe Kidney Cancer or Renal Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 36. Europe Kidney Cancer or Renal Cancer Market Size by Country (2019-2024) & (US$ Million)
 Table 37. Europe Kidney Cancer or Renal Cancer Market Size by Country (2025-2030) & (US$ Million)
 Table 38. Asia-Pacific Kidney Cancer or Renal Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 39. Asia-Pacific Kidney Cancer or Renal Cancer Market Size by Region (2019-2024) & (US$ Million)
 Table 40. Asia-Pacific Kidney Cancer or Renal Cancer Market Size by Region (2025-2030) & (US$ Million)
 Table 41. Latin America Kidney Cancer or Renal Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 42. Latin America Kidney Cancer or Renal Cancer Market Size by Country (2019-2024) & (US$ Million)
 Table 43. Latin America Kidney Cancer or Renal Cancer Market Size by Country (2025-2030) & (US$ Million)
 Table 44. Middle East & Africa Kidney Cancer or Renal Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 45. Middle East & Africa Kidney Cancer or Renal Cancer Market Size by Country (2019-2024) & (US$ Million)
 Table 46. Middle East & Africa Kidney Cancer or Renal Cancer Market Size by Country (2025-2030) & (US$ Million)
 Table 47. Novartis Company Details
 Table 48. Novartis Business Overview
 Table 49. Novartis Kidney Cancer or Renal Cancer Product
 Table 50. Novartis Revenue in Kidney Cancer or Renal Cancer Business (2019-2024) & (US$ Million)
 Table 51. Novartis Recent Development
 Table 52. Gilead Sciences Company Details
 Table 53. Gilead Sciences Business Overview
 Table 54. Gilead Sciences Kidney Cancer or Renal Cancer Product
 Table 55. Gilead Sciences Revenue in Kidney Cancer or Renal Cancer Business (2019-2024) & (US$ Million)
 Table 56. Gilead Sciences Recent Development
 Table 57. Roche Company Details
 Table 58. Roche Business Overview
 Table 59. Roche Kidney Cancer or Renal Cancer Product
 Table 60. Roche Revenue in Kidney Cancer or Renal Cancer Business (2019-2024) & (US$ Million)
 Table 61. Roche Recent Development
 Table 62. Bristol-Myers Squibb Company Details
 Table 63. Bristol-Myers Squibb Business Overview
 Table 64. Bristol-Myers Squibb Kidney Cancer or Renal Cancer Product
 Table 65. Bristol-Myers Squibb Revenue in Kidney Cancer or Renal Cancer Business (2019-2024) & (US$ Million)
 Table 66. Bristol-Myers Squibb Recent Development
 Table 67. Amgen Company Details
 Table 68. Amgen Business Overview
 Table 69. Amgen Kidney Cancer or Renal Cancer Product
 Table 70. Amgen Revenue in Kidney Cancer or Renal Cancer Business (2019-2024) & (US$ Million)
 Table 71. Amgen Recent Development
 Table 72. AstraZeneca Company Details
 Table 73. AstraZeneca Business Overview
 Table 74. AstraZeneca Kidney Cancer or Renal Cancer Product
 Table 75. AstraZeneca Revenue in Kidney Cancer or Renal Cancer Business (2019-2024) & (US$ Million)
 Table 76. AstraZeneca Recent Development
 Table 77. Merck & Co Company Details
 Table 78. Merck & Co Business Overview
 Table 79. Merck & Co Kidney Cancer or Renal Cancer Product
 Table 80. Merck & Co Revenue in Kidney Cancer or Renal Cancer Business (2019-2024) & (US$ Million)
 Table 81. Merck & Co Recent Development
 Table 82. Takeda Company Details
 Table 83. Takeda Business Overview
 Table 84. Takeda Kidney Cancer or Renal Cancer Product
 Table 85. Takeda Revenue in Kidney Cancer or Renal Cancer Business (2019-2024) & (US$ Million)
 Table 86. Takeda Recent Development
 Table 87. Merck KGaA Company Details
 Table 88. Merck KGaA Business Overview
 Table 89. Merck KGaA Kidney Cancer or Renal Cancer Product
 Table 90. Merck KGaA Revenue in Kidney Cancer or Renal Cancer Business (2019-2024) & (US$ Million)
 Table 91. Merck KGaA Recent Development
 Table 92. Seagen Company Details
 Table 93. Seagen Business Overview
 Table 94. Seagen Kidney Cancer or Renal Cancer Product
 Table 95. Seagen Revenue in Kidney Cancer or Renal Cancer Business (2019-2024) & (US$ Million)
 Table 96. Seagen Recent Development
 Table 97. Eli Lilly Company Details
 Table 98. Eli Lilly Business Overview
 Table 99. Eli Lilly Kidney Cancer or Renal Cancer Product
 Table 100. Eli Lilly Revenue in Kidney Cancer or Renal Cancer Business (2019-2024) & (US$ Million)
 Table 101. Eli Lilly Recent Development
 Table 102. Pfizer Company Details
 Table 103. Pfizer Business Overview
 Table 104. Pfizer Kidney Cancer or Renal Cancer Product
 Table 105. Pfizer Revenue in Kidney Cancer or Renal Cancer Business (2019-2024) & (US$ Million)
 Table 106. Pfizer Recent Development
 Table 107. GSK Company Details
 Table 108. GSK Business Overview
 Table 109. GSK Kidney Cancer or Renal Cancer Product
 Table 110. GSK Revenue in Kidney Cancer or Renal Cancer Business (2019-2024) & (US$ Million)
 Table 111. GSK Recent Development
 Table 112. Research Programs/Design for This Report
 Table 113. Key Data Information from Secondary Sources
 Table 114. Key Data Information from Primary Sources
 Table 115. Authors List of This Report


List of Figures
 Figure 1. Kidney Cancer or Renal Cancer Picture
 Figure 2. Global Kidney Cancer or Renal Cancer Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Kidney Cancer or Renal Cancer Market Share by Type: 2023 VS 2030
 Figure 4. Targeted Therapy Features
 Figure 5. Chemotherapy Features
 Figure 6. Immunotherapy Features
 Figure 7. Global Kidney Cancer or Renal Cancer Market Size by Application (2024-2030) & (US$ Million)
 Figure 8. Global Kidney Cancer or Renal Cancer Market Share by Application: 2023 VS 2030
 Figure 9. Hospital Case Studies
 Figure 10. Pharmacy Case Studies
 Figure 11. Other Case Studies
 Figure 12. Kidney Cancer or Renal Cancer Report Years Considered
 Figure 13. Global Kidney Cancer or Renal Cancer Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 14. Global Kidney Cancer or Renal Cancer Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global Kidney Cancer or Renal Cancer Market Share by Region: 2023 VS 2030
 Figure 16. Global Kidney Cancer or Renal Cancer Market Share by Players in 2023
 Figure 17. Global Top Kidney Cancer or Renal Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer or Renal Cancer as of 2023)
 Figure 18. The Top 10 and 5 Players Market Share by Kidney Cancer or Renal Cancer Revenue in 2023
 Figure 19. North America Kidney Cancer or Renal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 20. North America Kidney Cancer or Renal Cancer Market Share by Country (2019-2030)
 Figure 21. United States Kidney Cancer or Renal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Canada Kidney Cancer or Renal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe Kidney Cancer or Renal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Kidney Cancer or Renal Cancer Market Share by Country (2019-2030)
 Figure 25. Germany Kidney Cancer or Renal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. France Kidney Cancer or Renal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. U.K. Kidney Cancer or Renal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Italy Kidney Cancer or Renal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Russia Kidney Cancer or Renal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Nordic Countries Kidney Cancer or Renal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Asia-Pacific Kidney Cancer or Renal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Asia-Pacific Kidney Cancer or Renal Cancer Market Share by Region (2019-2030)
 Figure 33. China Kidney Cancer or Renal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Japan Kidney Cancer or Renal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. South Korea Kidney Cancer or Renal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Southeast Asia Kidney Cancer or Renal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. India Kidney Cancer or Renal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Australia Kidney Cancer or Renal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Latin America Kidney Cancer or Renal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Latin America Kidney Cancer or Renal Cancer Market Share by Country (2019-2030)
 Figure 41. Mexico Kidney Cancer or Renal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Brazil Kidney Cancer or Renal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Middle East & Africa Kidney Cancer or Renal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Middle East & Africa Kidney Cancer or Renal Cancer Market Share by Country (2019-2030)
 Figure 45. Turkey Kidney Cancer or Renal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Saudi Arabia Kidney Cancer or Renal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. UAE Kidney Cancer or Renal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. Novartis Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2019-2024)
 Figure 49. Gilead Sciences Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2019-2024)
 Figure 50. Roche Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2019-2024)
 Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2019-2024)
 Figure 52. Amgen Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2019-2024)
 Figure 53. AstraZeneca Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2019-2024)
 Figure 54. Merck & Co Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2019-2024)
 Figure 55. Takeda Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2019-2024)
 Figure 56. Merck KGaA Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2019-2024)
 Figure 57. Seagen Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2019-2024)
 Figure 58. Eli Lilly Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2019-2024)
 Figure 59. Pfizer Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2019-2024)
 Figure 60. GSK Revenue Growth Rate in Kidney Cancer or Renal Cancer Business (2019-2024)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Kidney Cancer Therapeutics Market Research Report 2025
Global Kidney Cancer Drugs Market Research Report 2024
Kidney Cancer Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Renal Cell Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Kidney Cancer Market Research Report 2025
Global Kidney Cancer Therapy Market Research Report 2024
Kidney Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Kidney Cancer Therapeutics and Diagnostics Market Insights Forecast to 2030
Global Kidney Cancer and Renal Cell Carcinoma RCC Drugs Market Insights Forecast to 2030
Global Renal Therapeutic Market Research Report 2025
Global Cancer Drug Therapy Market Insights Forecast to 2030
Global Bladder Cancer Therapeutics and Diagnostics Market Research Report 2024
Renal Cell Carcinoma Therapy Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Renal Diseases Drug Market Insights Forecast to 2030
Global End Stage Renal Disease Market Research Report 2024
Global Human Kidneys Models Market Research Report 2024
Global Kidney Cancer Molecular Diagnostics Market Research Report 2024
Global Kidney Chip Market Research Report 2024
Global Prostate Cancer Diagnostics Market Research Report 2025
Global Anatomy Kidneys Models Market Research Report 2024

RELATED REPORTS

Global Fixation Device for Radiotherapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4H16852
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Group A Streptococcus for Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K16619
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Boron Neutron Capture Therapy System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30U16301
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Radioactive Glass Microsphere Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2G16953
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions